Daily FNArena News - Australia

Both UBS and Deutsche Bank initiated coverage on Collins Foods with a Buy rating this week.

Goldman Sachs has initiated coverage on McMillan Shakespeare with a Buy rating, attracted to a solid earnings growth outlook and high returns on equity.

Cochlear has recalled its Nucleus 5 device and brokers have been quick to reassess the stock given the potential impact on both earnings and reputation.

Stockbroker Moelis believes investors should have Flight Centre on their radar.

With Asia expected to underpin significant increases to LNG demand, the Australian energy sector is tipped as a beneficiary.

With reporting season completed and earnings guidance from Oz REITs generally solid more brokers have reviewed the sector to update preferred exposures.

Post profit reports last month brokers have updated views on the engineering and contracting sector.

CSL’s profits are undermined by a rising Swiss franc, so what are the implications of last night’s intervention announcement from the Swiss National Bank?

The RBA today acknowledged global uncertainty, but gave no hint of a rate cut being nigh as it remained on hold at 4.75%.

The RBA today elected to keep its cash rate unchanged at 4.75%.